Teshiba Risa, Kawano Shinya, Wang Larry L, He Lejian, Naranjo Arlene, London Wendy B, Seeger Robert C, Gastier-Foster Julie M, Look A Thomas, Hogarty Michael D, Cohn Susan L, Maris John M, Park Julie R, Shimada Hiroyuki
1 Department of Pathology & Laboratory Medicine, Children's Hospital Los Angeles, and University of Southern California Keck School of Medicine, 4650 Sunset Boulevard, MS #43, Los Angeles, CA 90027, USA.
Pediatr Dev Pathol. 2014 Nov-Dec;17(6):441-9. doi: 10.2350/14-06-1505-OA.1. Epub 2014 Sep 10.
Prognostic effects of Mitosis-Karyorrhexis Index (MKI) used in the International Neuroblastoma Pathology Classification (INPC) are age-dependent. A total of 4,282 neuroblastomas reviewed at the Children's Oncology Group Neuroblastoma Pathology Reference Laboratory (8/1/2001-3/31/2012) included 2,365 low-MKI (L-MKI), 1,068 intermediate-MKI (I-MKI), and 849 high-MKI (H-MKI) tumors. Cox proportional hazards models were fit to determine age cut-offs at which the relative risk of event/death was maximized in each MKI class. Backward-selected Cox models were fit to determine the prognostic strength of the age cut-offs for survival in the presence of other prognostic factors. The age cut-offs used in the INPC for L-MKI tumors (<60 months, n = 2,710, 84.0% ± 1.0% event-free survival [EFS], 93.8 ± 0.7% overall survival [OS] vs ≥60 months, n = 195, 49.8% ± 4.6% EFS, 71.7% ± 4.1% OS; P < 0.0001) and I-MKI tumors (<18 months, n = 568, 83.8% ± 2% EFS, 93.7% ± 1.3% OS vs ≥18 months, n = 500, 51.4% ± 2.9% EFS, 66.7% ± 2.7% OS; P < 0.0001) were within the effective range for distinguishing prognostic groups. As for H-MKI tumors (no cut-off age in the INPC, 51.0% ± 2.2% EFS, 64.4% ± 2.1% OS), a new cut-off of 3-4 months was suggested (<4 months, n = 38, 82.3% ± 8.4% EFS, 81.8% ± 8.5% OS vs ≥4 months, n = 811, 49.6% ± 2.2% EFS, 63.7% ± 2.1% OS, P = 0.0034 and 0.0437, respectively). Multivariate analyses revealed that cut-offs of 60 and 18 months for L-MKI and I-MKI tumors, respectively, were independently prognostic. However, the cut-off of 4 months for H-MKI tumors did not reach statistical significance in the presence of other factors. The age cut-offs for MKI classes (60 months for L-MKI, 18 months for I-MKI, no cut-off for H-MKI) in the current INPC are reasonable and effective for distinguishing prognostic groups with increased risk of event/death for older patients.
国际神经母细胞瘤病理分类(INPC)中使用的有丝分裂-核固缩指数(MKI)的预后影响与年龄有关。儿童肿瘤学组神经母细胞瘤病理参考实验室(2001年8月1日至2012年3月31日)共审查了4282例神经母细胞瘤,其中包括2365例低MKI(L-MKI)、1068例中等MKI(I-MKI)和849例高MKI(H-MKI)肿瘤。采用Cox比例风险模型确定年龄分界点,使每个MKI类别中事件/死亡的相对风险最大化。采用向后选择的Cox模型确定在存在其他预后因素的情况下年龄分界点对生存的预后强度。INPC中用于L-MKI肿瘤的年龄分界点(<60个月,n = 2710,无事件生存[EFS]率为84.0%±1.0%,总生存[OS]率为93.8±0.7%;≥60个月,n = 195,EFS率为49.8%±4.6%,OS率为71.7%±4.1%;P<0.0001)和I-MKI肿瘤(<18个月,n = 568,EFS率为83.8%±2%,OS率为93.7%±1.3%;≥18个月,n = 500,EFS率为51.4%±2.9%,OS率为66.7%±2.7%;P<0.0001)在区分预后组的有效范围内。至于H-MKI肿瘤(INPC中无分界年龄,EFS率为51.0%±2.2%,OS率为64.4%±2.1%),建议新的分界点为3 - 4个月(<4个月,n = 38,EFS率为82.3%±8.4%,OS率为81.8%±8.5%;≥4个月,n = 811,EFS率为49.6%±2.2%,OS率为63.7%±2.1%,P分别为0.0034和0.0437)。多因素分析显示,L-MKI和I-MKI肿瘤的分界点分别为60个月和18个月具有独立预后意义。然而,H-MKI肿瘤4个月的分界点在存在其他因素时未达到统计学意义。当前INPC中MKI类别的年龄分界点(L-MKI为60个月,I-MKI为18个月,H-MKI无分界点)对于区分老年患者中事件/死亡风险增加的预后组是合理且有效的。